TY  - JOUR
T1  - SOy isoflavone supplementation in menopausal women
AU  - Miller LE, Stewart ME
Y1  - 2011/12/12
N1  - 10.1001/archinternmed.2011.582
JO  - Archives of Internal Medicine
SP  - 2067
EP  - 2068
VL  - 171
IS  - 22
N2  - 
Through 2 years, subject attrition rates were 18.8% with soy isoflavone and 34.1% for placebo (P = .008). While the authors state that the baseline characteristics of the subjects who completed the trial were similar to those who withdrew, this explanation is inadequate. Were the reasons for study discontinuation available for comparison? It is unlikely that a discrepancy of this magnitude would occur by chance alone.

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2011.582
UR  - http://dx.doi.org/10.1001/archinternmed.2011.582
ER  -